Regulax Picosulfate

Quick links

Choose a section

Quick links to important sections

Advertisements

Regulax Picosulfate

Selected form

Advertisements
Advertisements

Method of action: Laxative

Treatment option: Hemorrhoids, Constipation, Proctitis

Advertisements

Overview of Regulax Picosulfate

Property Description
Active ingredient Sodium Picosulfate (INN)
Form Oral drops solution, Oral solution
Pharmacological class Stimulant Laxative (Contact Laxative)
Common use Relief of short-term, occasional constipation
Origin Synthetic compound (Triarylmethane group)

Regulax Picosulfate is a pharmaceutical product primarily containing the active substance, Sodium Picosulfate (INN). This medicine is scientifically classified as a stimulant laxative, a type of contact laxative used specifically to promote effective bowel movements. This classification is precise, as it groups the compound under the ATC code A06AB08, placing it in the category of drugs that directly act on the intestinal lining.

As a complex synthetic compound, Sodium Picosulfate is part of the Triarylmethane group of laxative agents, whose unique characteristics differentiate it from osmotic or bulk-forming laxatives. The drug’s formulation is based on the single-active ingredient, Sodium Picosulfate, which is commonly prepared as an Oral drops solution in an aqueous-based vehicle for ease of administration. This drop formulation is clinically recognized for its utility in tailoring relief to individual needs.

The primary therapeutic purpose of Regulax Picosulfate is to relieve the common symptom of constipation by restoring effective elimination. This medicine has a recognized role in short-term constipation management. The medicine’s efficacy stems from its prodrug nature, ensuring its localized activation in the colon, which ultimately encourages the necessary muscle contractions (peristalsis) for effective passage.

Advertisements

What side effects are possible with Regulax Picosulfate?

Possible side effects and safety information

The safety profile of Regulax Picosulfate, which contains sodium picosulfate, is formally classified in regulatory documents according to the frequency and body system affected. Most officially listed adverse reactions involve the gastrointestinal and nervous systems.

Frequency-Classified Adverse Reactions

The most commonly classified adverse reactions include Diarrhoea (Very Common, ge1/10) and several effects classified as Common (ge1/100 to <1/10), such as abdominal pain, abdominal cramps, and headache. Less common effects may include dizziness and nausea (Uncommon, ge1/1,000 to <1/100).

Reactions classified as Rare (ge1/10,000 to <1/1,000) include severe hypersensitivity like an anaphylactic reaction, and serious electrolyte changes such as hyponatraemia or hypokalaemia. Events reported in the post-marketing setting for which frequency cannot be estimated (Not Known) include syncope and generalized skin reactions.

Serious Safety Constraints and Patterns

The regulatory label highlights that long-term excessive use of stimulant laxatives may be associated with risks of fluid and electrolyte imbalance and potential harm to intestinal function, including the rare possibility of developing a cathartic colon.

Serious adverse reactions documented in official sources include severe fluid and electrolyte abnormalities and complications such as colonic mucosal ulceration (ileal ulcer) and toxic megacolon. These risks define key constraints, and use is formally contraindicated in patients with conditions like gastrointestinal obstruction or ileus and severe dehydration.

Safety notes also indicate that older adults are officially considered to have an increased susceptibility to the effects of fluid loss.

Advertisements

Overdose and Emergency Response

Officially Documented Overdose Manifestations

Overdose of Regulax Picosulfate, including cases of chronic overuse, is officially documented as leading to significant physiological consequences arising from its pronounced laxative effect. Acute presentation is characterized by severe diarrhoea and abdominal cramping, which result in a clinically significant loss of fluid and electrolytes, especially potassium (Hypokalaemia). Chronic laxative abuse has been formally linked to conditions such as persistent abdominal pain, Metabolic Alkalosis, and renal tubular damage.

Severe Outcomes and Emergency Action

The immediate regulatory concern is that severe fluid and electrolyte derangement elevates the risk of serious systemic outcomes. Officially documented severe manifestations include complications such as cardiac arrhythmia and seizures.

Due to these potential outcomes, regulatory agencies mandate that individuals seek immediate medical attention for any suspected overdose. Urgent medical help is required if the person experiences symptoms like collapse, seizure, or is unable to be awakened. Management is described as symptomatic and supportive treatment, focusing on the replacement of lost fluids and the correction of electrolyte imbalance. No specific antidote is known. Furthermore, the official labeling notes that the elderly and the young are more susceptible to the effects of dehydration, emphasizing the criticality of prompt intervention within these populations.

Advertisements

Therapeutic Uses of Regulax Picosulfate

Main uses of Regulax Picosulfate

Regulax Picosulfate is a stimulant laxative used for the short-term relief of occasional constipation. Its primary function is to facilitate bowel movements in individuals experiencing difficulty or infrequency in passing stool.

Mechanisms of action

The active ingredient, sodium picosulfate, undergoes a transformation in the large intestine. Once it reaches the colon, naturally occurring bacteria break down the substance into its active form. This process ensures that the effect is localized primarily within the lower digestive tract.

The active metabolite works in two ways:

  • Stimulation of motility: It acts directly on the nerve endings in the walls of the large intestine, increasing the muscle contractions (peristalsis) that move waste through the system.
  • Fluid accumulation: It helps to reduce the absorption of water and electrolytes from the colon and can increase the secretion of water into the intestinal lumen. This softens the stool, making it easier to pass.

Benefits in clinical use

Targeted relief

Because the substance is activated specifically by colonic bacteria, the primary action is concentrated in the colon rather than the stomach or small intestine. This targeted approach is intended to minimize interference with the earlier stages of digestion and nutrient absorption.

Predictability

Regulax Picosulfate is typically characterized by a predictable onset of action. When taken as required, the effect generally occurs within several hours, allowing for a planned resolution of constipation symptoms.

Versatility in patient care

This laxative is used in various clinical scenarios where bowel evacuation is necessary. Beyond the management of simple constipation, it may be utilized in medical settings to empty the colon prior to diagnostic procedures, such as radiological examinations or endoscopic evaluations, or before surgical interventions where a clear bowel is required for safety and visibility.

Regulatory References

  1. NHS guidance on Stimulant Laxatives
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Official Regulatory Information

The eligibility for Regulax Picosulfate (Sodium Picosulfate) is defined by regulatory authorities based on age, acute health status, and other patient populations.

Absolute Contraindications (Must Not Use)

Use is strictly prohibited for individuals with ileus or intestinal obstruction, severe dehydration, gastrointestinal ulceration or perforation, and acute inflammatory bowel diseases (including acute appendicitis or toxic colitis). The medicine is also contraindicated in patients with known hypersensitivity to the active ingredient or any excipients.


Age-Group and Conditional Restrictions

Population Group Eligibility Status
Adults and Adolescents Approved for use (typically ge 10 or 12 years).
Children under minimum age Use not recommended without medical advice.
Pregnancy (especially first trimester) Conditional Restriction; use only if benefit outweighs risk.
Lactation Established Eligibility; considered acceptable for use.
Renal/Hepatic Impairment Caution required due to risk of fluid imbalance.

Regulatory documents advise caution for elderly patients and those with heart disease due to increased susceptibility to fluid and electrolyte disturbances.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Sodium Picosulfate is officially documented by regulatory authorities, focusing on pharmacokinetic interference and pharmacodynamic risks related to fluid balance. The medicine's laxative action can cause pharmacokinetic interference; therefore, co-administration with other oral medications may result in their reduced absorption or lower systemic exposure. Regulatory labeling mandates that other oral medications should not be taken within one hour of starting the treatment dose.

A separate pharmacodynamic risk exists when co-administering with certain drug classes that also impact electrolytes. Concurrent use with diuretics or adreno-corticosteroids may increase the risk of electrolyte imbalance. This imbalance, specifically hypokalaemia, can lead to increased sensitivity to cardiac glycosides, such as Digoxin. Official labeling further advises caution with medications that lower the seizure threshold, due to the potential for electrolyte abnormalities to increase this risk.

Regarding efficacy, broad spectrum antibiotics may reduce the laxative action of Sodium Picosulfate by interfering with the necessary bacterial activation in the colon. Furthermore, regulatory documents strictly prohibit the concurrent use of other laxatives due to the additive purgative effect. Consumption of alcohol is also restricted due to increased risk of dehydration and dizziness.

Advertisements

Mechanism of Action

The mechanism of Sodium Picosulfate is entirely localized to the colon and involves a precise sequence of metabolic activation followed by a dual physiological action: direct secretomotor stimulation and fluid transport modulation.


Prodrug Activation by Colonic Bacteria

Sodium Picosulfate is a prodrug that is inert until it is chemically converted by the indigenous bacterial enzymes (sulfatases) in the large intestine. This conversion is necessary to generate the pharmacologically active molecule, BHPM , confining the active molecule's stimulatory action exclusively to the large intestine. This activation step determines the time required for the molecule to initiate its effect, as it depends on intestinal transit and enzymatic action.


Direct Stimulation of Motility and Secretion

The active metabolite acts as a contact laxative by directly stimulating the colonic mucosal lining and the underlying enteric sensory nerve endings. This neurogenic reflex significantly increases the frequency and force of peristaltic contractions (propulsive movements). Simultaneously, the mechanism shifts fluid homeostasis by inhibiting net water absorption and promoting electrolyte and water secretion into the intestinal lumen.


Resulting Dual Physiological Effect

The combined effect of the mechanism is an accelerated transit time due to enhanced motility and a significant increase in the volume and hydration of the contents. This dual physiological adjustment results in increased propulsion and a softer, bulkier fecal mass. The mechanism facilitates the mechanical process by creating accelerated transit and a change in stool quality. The mechanism’s dependence on the colonic microflora defines a biological constraint on its action.

Advertisements

Dosage and Administration Information

Regulax Picosulfate (sodium picosulfate, often combined with magnesium citrate) is a laxative used for short-term relief of occasional constipation or for bowel cleansing prior to a medical procedure like a colonoscopy. The appropriate method of use is dependent on the treatment purpose.

Administration Guidelines

  • For Constipation: The liquid formulation is generally taken once daily, usually at bedtime, as its effects typically begin within 6 to 12 hours. The adult dose is generally 5–10 mL of liquid, starting with the lower dose and increasing only if necessary. This medication should be used for a maximum of five days unless otherwise directed by a healthcare professional, as overuse may be harmful.
  • For Bowel Cleansing (e.g., before Colonoscopy): The regimen requires two separate doses, often provided as powder packets to be mixed with cold water immediately before ingestion. The Split-Dose regimen is often preferred, involving the first dose the evening before the procedure and the second dose the following morning, several hours prior to the exam.

Important Considerations

  • Hydration: It is critical to consume a required volume of clear liquids following each dose of the bowel cleansing preparation to prevent dehydration and electrolyte abnormalities. Patients should follow the liquid intake schedule provided with the prescription.
  • Timing of Oral Medications: Other oral medications should generally not be taken within one hour before or one hour after taking this product, as its effect may reduce the absorption of other medicines.
  • Diet: A clear liquid diet is typically required on the day before a colonoscopy, and solid food and dairy must be avoided.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Regulax Picosulfate is a stimulant laxative containing the active ingredient sodium picosulfate. Research has evaluated its use for the short-term relief of occasional constipation and, often in combination with an osmotic agent like magnesium citrate, for bowel cleansing prior to diagnostic procedures such as colonoscopy.

Constipation Management

Randomized, controlled trials (RCTs) investigating sodium picosulfate monotherapy for chronic functional constipation typically use intervention periods of up to four weeks. These studies generally focus on patient outcomes such as the mean number of complete spontaneous bowel movements (CSBMs) per week.

  • CSBM Frequency: Clinical data reported an increase in weekly CSBMs compared to placebo in patients with chronic constipation. An analysis of pooled data from two RCTs suggested that the group receiving the active drug had a significant increase in the frequency of bowel movements.
  • Quality of Life: Studies have also explored the impact of the treatment on patient-reported quality of life, often using tools like the Patient Assessment of Constipation Quality of Life (PAC-QOL) questionnaire. Improvements in subscale scores related to physical discomfort and satisfaction with bowel function were observed.

Bowel Preparation

Sodium picosulfate, often combined with magnesium citrate (SPMC), has been extensively studied for colon cleansing. Trials compare SPMC to large-volume preparations like polyethylene glycol (PEG).

  • Cleansing Efficacy: Split-dosing regimens (taking the preparation in two separate doses) of SPMC have frequently been evaluated. Studies have shown that SPMC cleansing efficacy is often comparable or non-inferior to that of PEG solutions when assessed using standardized scales, such as the Boston Bowel Preparation Scale (BBPS).
  • Patient Tolerability: Several comparative trials indicate that SPMC preparations may be associated with higher patient satisfaction and tolerability than high-volume PEG preparations, often due to the lower fluid intake required. Adverse events in studies are typically mild and gastrointestinal in nature, including abdominal cramps and nausea.

Key Studies & References

  1. Systematic review and meta-analysis: Sodium picosulphate with magnesium citrate as bowel preparation for colonoscopy (Focus on validated tools)
  2. Sodium Picosulfate Ferring 5mg Tablets - Summary of Product Characteristics (for indication/regulatory context)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Regulax Picosulfate (FAQ)


Q: What is the main difference between Regulax Picosulfate and other common laxatives?

A: According to official documents, the active ingredient, sodium picosulfate, is classified as a stimulant laxative. A notable characteristic is that it is a prodrug, meaning it remains inactive until it is converted by bacteria in the colon into its working form. For bowel cleansing, the product is often formulated in combination with an osmotic laxative to provide a dual mechanism of action.

Q: What are the most common side effects people report when taking Regulax Picosulfate?

A: Studies and official information indicate that common adverse effects include abdominal pain or cramping, nausea, headache, and dizziness. Because the product works by accelerating movement through the gut, the passage of loose or watery stools (diarrhea) is an expected result of taking the medication.

Q: Is it normal to feel dehydrated after using Regulax Picosulfate?

A: The expected action of the medication can lead to significant fluid loss, which may result in fluid or electrolyte disturbances. Official warnings state that signs of dehydration, such as excessive thirst or dizziness, may occur if inadequate fluids are consumed. Adequate hydration is recognized as critical in managing fluid loss risk.

Q: Are there any known long-term side effects from using Regulax Picosulfate?

A: Regulatory advice states that the product is not recommended for daily use beyond five days without investigating the cause of the constipation. Prolonged or excessive use may lead to disturbances in fluid and electrolyte balance. Official information also notes that long-term use of stimulant laxatives may potentially affect the normal function of the colon.

Q: Does Regulax Picosulfate interact with common pain relievers like ibuprofen or acetaminophen?

A: According to regulatory labeling, the laxative effect of this medicine may alter the body's absorption of other oral medications taken at the same time. Official product information generally states that other oral medications should be avoided within one hour of taking Regulax Picosulfate. This practice is advised to reduce the risk of reduced effectiveness of the other medication.

Q: Are there certain foods or drinks that should be avoided while using this medicine?

A: Official patient information for the bowel cleansing regimen specifies that solid foods and milk must be avoided. Separately, regulatory documents advise that the consumption of alcohol is restricted during therapy due to an increased risk of dehydration and dizziness.

Q: Do you need to drink extra water when taking Regulax Picosulfate?

A: Official instructions strongly emphasize the essential nature of maintaining adequate fluid intake throughout the course of treatment. This is particularly critical when using the product for bowel cleansing, as it helps to compensate for the resulting fluid loss and prevent dehydration.

Q: If I am taking diuretics (water pills), can I still use Regulax Picosulfate?

A: Official documents advise that caution should be exercised if this product is used concurrently with medications that affect water or electrolyte balance, such as diuretics or corticosteroids. This is due to a potentially increased risk of a specific electrolyte imbalance known as hypokalemia (low potassium).

Q: Does Regulax Picosulfate affect the absorption of birth control pills?

A: Regulatory labeling advises that the potent laxative effect of this product may reduce the absorption of other oral medications, including oral contraceptives, if taken too closely together. Therefore, official documents state that co-administration of oral medications within one hour of the treatment dose is generally avoided.

Q: Can Regulax Picosulfate be mixed with juice or other liquids?

A: For the powder formulation often used for bowel cleansing, official instructions specify mixing the packet contents with cold water. However, patient information for liquid drop formulations may state that the drops can be taken with or without other liquids.

Q: Does Regulax Picosulfate work the same way for everyone?

A: Official documents note that the drug's mechanism relies on its conversion into the active form by the indigenous bacteria (microflora) living in the colon. Because the bacterial composition in the gut can vary significantly among individuals, the time it takes for the drug to start working, and its overall effect, may also vary.

Q: Is Regulax Picosulfate absorbed into the bloodstream?

A: Studies and official pharmacokinetic data indicate that the active ingredient has minimal systemic absorption into the bloodstream. The action of the medication is primarily local, occurring in the large intestine where it is converted into its working form.

Q: Does Regulax Picosulfate cause bloating or excess gas?

A: Official patient information notes that some people may experience bloating or an upset stomach before the product's full laxative effect begins. This is common with laxative products that increase fluid volume and motility in the gut.

Q: Is Regulax Picosulfate the same thing as sodium picosulfate?

A: Regulax Picosulfate is a brand name used for a product whose active pharmaceutical ingredient is sodium picosulfate. Therefore, these names refer to the marketed product and its core therapeutic component, respectively.

Q: Does Regulax Picosulfate come in different strengths?

A: Yes, the active ingredient, sodium picosulfate, is available in different strengths and formulations depending on the manufacturer and the intended use. These formulations can include different concentrations of oral drops or tablet strengths (e.g., 5 mg or 10 mg).

Q: Is Regulax Picosulfate available over-the-counter or is it prescription-only?

A: The regulatory status often depends on the product's concentration and intended use. Products containing sodium picosulfate for short-term constipation relief are often available for general sale or under pharmacy supervision. However, the higher-dose combination products used for bowel cleansing are typically restricted to prescription-only status ( Rx-only).

Q: Is Regulax Picosulfate safe for use during pregnancy or breastfeeding?

A: For breastfeeding, official information indicates that the active substance is likely compatible, as studies suggest the working component is undetectable in breast milk. Regarding pregnancy, use should only occur on the recommendation and advice of a healthcare professional.

Q: Can elderly patients or seniors use Regulax Picosulfate?

A: Yes, the product is indicated for use in the adult population, which includes the elderly. However, regulatory warnings advise that care should be taken when administering the product to seniors. Elderly patients are noted to be more susceptible to the effects of dehydration, and maintaining adequate fluid intake is critical.

Q: Is Regulax Picosulfate considered safe for use in children?

A: Official documents differentiate between uses and age groups. For general constipation relief, use of stimulant laxatives in children under 12 years requires advice from a prescriber. For the combination product used in bowel cleansing, it is established as safe and effective for pediatric patients 9 years of age and older but not for younger children.

Q: Does Regulax Picosulfate contain sugar, gluten, or common allergens?

A: The inclusion of non-active ingredients, known as excipients, can vary depending on the product's formulation (liquid, tablet, or powder). Regulatory documents list these excipients, which may include components like sorbitol or lactose. Information regarding specific allergens or sugars is detailed in the full ingredient list for the specific product.

Q: Is it possible to become dependent on Regulax Picosulfate?

A: Official regulatory advice cautions against using the product daily for more than five days without investigating the cause of constipation. Prolonged and excessive use of stimulant laxatives may potentially cause the bowel to lose its natural function, leading to a condition sometimes referred to as 'cathartic colon'.

Q: Can Regulax Picosulfate be used by people with diabetes?

A: Regulatory warnings mention the need for hypoglycemia (low blood sugar) monitoring in certain pediatric uses of the combination product. For adults with diabetes, there is no general contraindication, but it is important to check the product's excipients (inactive ingredients), as some formulations may contain sugars that could affect blood glucose levels.

Q: Does Regulax Picosulfate need to be refrigerated?

A: General storage requirements state that the product should be kept in a dry, cool, and well-ventilated place with containers tightly closed. Specific temperature requirements, including whether refrigeration is necessary for a particular liquid formulation, is best confirmed by referring to the manufacturer's patient leaflet.

Q: What are the signs of taking too much Regulax Picosulfate?

A: Symptoms of taking too much include diarrhea, severe abdominal cramps, and a clinically significant loss of potassium and other electrolytes. Regulatory reports also note that with considerably high doses, cases of reduced blood flow to the colon lining have been reported.

Q: Has Regulax Picosulfate been studied in people with kidney disease?

A: Regulatory documents state that the product is contraindicated in patients with severe renal impairment (a specific measure of kidney function). For people with mild to moderate kidney disease, caution is advised because the drug's effects may be increased due to the body's slower elimination process.

Q: Is Regulax Picosulfate sold under other brand names?

A: Yes, the active ingredient, sodium picosulfate, is sold globally under numerous brand names. Examples include Laxoberal, Picolax, and Guttalax. When combined with other agents for bowel cleansing, it is also sold under names like Prepopik and Clenpiq.

Q: Are there any specific medical conditions that prevent someone from using Regulax Picosulfate?

A: Official regulatory documents list several medical conditions that prevent the use of this product (contraindications). These conditions include gastrointestinal obstruction or ileus, bowel perforation, severe dehydration, and acute abdominal surgical conditions like appendicitis or acute inflammatory bowel diseases.

Q: Can people with irritable bowel syndrome (IBS) use Regulax Picosulfate?

A: Regulatory labeling advises caution in patients with inflammatory bowel disease and specifically contraindicates use in acute inflammatory bowel diseases. As the medication causes significant bowel movement and common side effects include abdominal pain and cramping, these risks are relevant to patients with pre-existing gastrointestinal sensitivity.

Q: Does using Regulax Picosulfate affect sleep patterns?

A: While the official side effect profile does not specifically mention sleep patterns, it does list common neurological effects such as headache and dizziness. Since the product is often taken at bedtime due to its 6-to-12-hour onset of effect, any such effects could potentially overlap with sleep hours.

Q: Can people with high blood pressure safely use Regulax Picosulfate?

A: Regulatory documents advise caution in patients at increased risk of cardiac issues, such as those with uncontrolled arrhythmias or congestive heart failure. Clinical trials have documented changes in blood pressure and heart rate, specifically orthostatic hypotension (a drop in blood pressure upon standing), that may occur during treatment.

Advertisements

How should Regulax Picosulfate be stored and disposed of?

How to Store and Dispose of Regulax Picosulfate

The storage and disposal of the medicine must strictly adhere to the conditions specified on the official product labeling.


Storage Requirements

Condition
Temperature Restriction The product must not be stored above 30, C.
Protection Store in the original package in order to protect the contents from moisture.
Access Control The medicine must be kept out of the sight and reach of children.
Stability Do not use the product after the expiry date. Single-use sachets must be used immediately upon opening, and any unused solution must be discarded.

Disposal Instructions

Any unused medicinal product or waste material must be disposed of in accordance with local requirements. Government guidelines state that if a medication take-back program is unavailable, the product should be mixed with an undesirable substance (such as dirt) and sealed before being placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Regulax Picosulfate found in:

A-Z Index: